A novel MEK2/PI3Kδ pathway controls the expression of IL-1 receptor antagonist in IFN-β-activated human monocytes
Published 2010 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A novel MEK2/PI3Kδ pathway controls the expression of IL-1 receptor antagonist in IFN-β-activated human monocytes
Authors
Keywords
-
Journal
JOURNAL OF LEUKOCYTE BIOLOGY
Volume 88, Issue 6, Pages 1191-1200
Publisher
Wiley
Online
2010-09-14
DOI
10.1189/jlb.0510312
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Toll-Like Receptor-Mediated Production of IL-1Ra Is Negatively Regulated by GSK3 via the MAPK ERK1/2
- (2014) K. Rehani et al. JOURNAL OF IMMUNOLOGY
- Dissecting the role of the 3-phosphoinositide-dependent protein kinase-1 (PDK1) signalling pathways
- (2011) Jose R. Bayascas CELL CYCLE
- Akt and mRNA translation by interferons
- (2010) Surinder Kaur et al. CELL CYCLE
- Active Mek2 as a regulatory scaffold that promotes Pin1 binding to BPGAP1 to suppress BPGAP1-induced acute Erk activation and cell migration
- (2010) Catherine Qiurong Pan et al. JOURNAL OF CELL SCIENCE
- The p110δ structure: mechanisms for selectivity and potency of new PI(3)K inhibitors
- (2010) Alex Berndt et al. Nature Chemical Biology
- Distinct effects of knocking down MEK1 and MEK2 on replication of herpes simplex virus type 2
- (2010) Hao Zhang et al. VIRUS RESEARCH
- Horror Autoinflammaticus: The Molecular Pathophysiology of Autoinflammatory Disease
- (2009) Seth L. Masters et al. Annual Review of Immunology
- Immunological and Inflammatory Functions of the Interleukin-1 Family
- (2009) Charles A. Dinarello Annual Review of Immunology
- TLR4/MyD88/PI3K interactions regulate TLR4 signaling
- (2009) Michelle H. W. Laird et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Regulation of Akt(ser473) phosphorylation by Choline kinase in breast carcinoma cells
- (2009) Boon Chua et al. Molecular Cancer
- A Mek1–Mek2 heterodimer determines the strength and duration of the Erk signal
- (2009) Federica Catalanotti et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- An Autoinflammatory Disease with Deficiency of the Interleukin-1–Receptor Antagonist
- (2009) Ivona Aksentijevich et al. NEW ENGLAND JOURNAL OF MEDICINE
- Glatiramer acetate increases IL-1 receptor antagonist but decreases T cell-induced IL-1 in human monocytes and multiple sclerosis
- (2009) D. Burger et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- MAP kinase: It’s been longer than fifteen minutes
- (2008) Thomas W. Sturgill BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Activation of MEK1 or MEK2 isoform is sufficient to fully transform intestinal epithelial cells and induce the formation of metastatic tumors
- (2008) Laure Voisin et al. BMC CANCER
- Induction of serum soluble tumor necrosis factor receptor II (sTNF-RII) and interleukin-1 receptor antagonist (IL-1ra) by interferon beta-1b in patients with progressive multiple sclerosis
- (2008) M. Comabella et al. JOURNAL OF NEUROLOGY
- Differential regulation of cytokine production by PI3Kδ in human monocytes upon acute and chronic inflammatory conditions
- (2008) Nicolas Molnarfi et al. MOLECULAR IMMUNOLOGY
- MEK1 and MEK2 regulate distinct functions by sorting ERK2 to different intracellular compartments
- (2007) Ellen Skarpen et al. FASEB JOURNAL
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now